Melanoma Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have a skin lesion that a doctor has examined during an in-person visit
- People whose doctor has decided to send their case for a teledermoscopy referral (a remote specialist review of skin images)
Who may not be able to join:
- People who are unable or unwilling to take part in the study
- People who are younger than 15 years old
- People whose skin lesion images are of too poor a quality to be reviewed
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Asa Ingvar, PhD, Department of Dermatology, Skane University Hospital, Region Skane, Sweden
Phone: +4646172243
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Effect on referral patterns; Effect on diagnostic accuracy due to availability of artificial intelligence; Risk of undetected skin cancer; Artificial intelligence timing and effect on diagnostic accuracy and willingness to rethink the preliminary diagnosis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.